Related Experiment Video
Updated: May 5, 2026

00:09
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
9.4K
Enhancing clinical utility: deep learning-based embryo scoring model for non-invasive aneuploidy prediction
Bing-Xin Ma1, Guang-Nian Zhao2,3, Zhi-Fei Yi1
1Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Reproductive Biology and Endocrinology : RB&E
|May 22, 2024
Summary
An AI-driven deep learning algorithm, the intelligent data analysis (iDA) Score, shows promise in predicting embryo ploidy non-invasively. This may offer a more accessible alternative to traditional preimplantation genetic testing for aneuploidies (PGT-A).
Area of Science:
- Reproductive biology
- Artificial intelligence in medicine
- Genetics
Background:
- Preimplantation genetic testing for aneuploidies (PGT-A) is effective but resource-intensive.
- There is a need for more accessible, non-invasive methods for assessing embryo ploidy.
- AI-driven image analysis offers potential for objective embryo assessment.
Purpose of the Study:
- To evaluate the clinical applicability of an AI-based deep learning algorithm for predicting embryo ploidy.
- To assess the performance of the intelligent data analysis (iDA) Score in identifying euploid embryos.
Main Methods:
- Retrospective analysis of 3448 biopsied blastocysts from 979 Time-lapse (TL)-PGT cycles.
- Application of the iDA Score, a deep learning algorithm, to assign scores (1.0-9.9) to blastocysts.
- Multivariate logistic regression analysis incorporating clinical and embryonic characteristics.
Main Results:
- Significant differences in iDA Scores were observed between blastocysts with varying ploidy.
- Higher iDA Scores strongly correlated with euploidy (p < 0.001).
- The iDA Score alone achieved an Area Under the Curve (AUC) of 0.612 for predicting euploidy, increasing to 0.688 when combined with other factors.
Conclusions:
- The iDA Score demonstrates potential as a non-invasive, cost-effective tool for embryo ploidy assessment.
- This AI-driven approach could benefit patients unable to undergo or afford traditional PGT-A.
- Accuracy of embryo ploidy prediction remains contingent on confirmatory next-generation sequencing (NGS) analysis.

